depression on glp 1 GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and GLP1s and depression probably have

Foundayo (orforglipron) received FDA approval in April 2026, and oral Wegovy tablets received FDA-approval in December 2025

At Coachlight, each plan is customized to your goals, medical history, and lifestyle

This perspective strengthens the rationale for investigating Bacteroides not only as a diagnostic marker but also as a potential therapeutic target for modulating the shared disease susceptibility underlying T2DM, AD, and PCOS

The Navigage Foundation is enhancing the lives of older people through the support of housing, health, education and human services

How GLP-1 and GIP Medications Work Differently to Support Weight Loss Introduction to GLP-1 and GIP Medications GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) medications represent two significant advancements in the field of weight loss pharmacotherapy